Early Enough Detection Can Change Everything
Leveraging the power of extracellular vesicles (EVs) to deliver near-patient diagnostic solutions that enable patients and physicians to win the battle against disease, improving and saving lives.
Making Reliable Early Disease
Detection Accessible to All
At Xzōm, we are focused on creating accessible and sensitive diagnostic solutions for diseases that currently lack effective early detection methods. Our aim is to bring these vital tools to more communities, meaning access to cutting-edge diagnostics no longer depends on living near a major medical or cancer center.
Our early disease detection platform is low-cost, easy-to-use, and leverages the power of biomarker-rich exosomes to transform outcomes for patients everywhere.
- One platform, multiple applications
- Low cost, easy-to-use near-patient platform
- Minimal sample volume (<100 µL)
- Rapid results
- Diagnostic and on going patient monitoring
Setting a New Standard
for Early Disease Detection
Xzōm’s novel near-patient platform utilizes a proprietary Alternating Current Electrokinetics (ACE) technology to rapidly isolate and accurately analyze exosomes from minimal blood samples in less than 30 minutes.
Our pioneering work begins with tackling one of the toughest challenges: developing a new approach for the early detection of pancreatic cancer. This is just the starting point. Xzōm’s versatile platform technology is engineered for broad impact, with a pipeline of further applications anticipated across oncology and other critical disease areas where timely detection can transform outcomes.
Exosomes: Biology’s Key to Superior Diagnostics
Unlike cell-free DNA (cfDNA), which is primarily released during cell death, exosomes are continuously secreted by living cells, offering earlier and more dynamic access to vital biological information. Often called the body’s “delivery trucks” for cell-to-cell communication, exosomes carry diverse cargo — DNA, RNA, and proteins — the entire “central dogma” of molecular biology. Exosomes are also significantly more abundant than cfDNA in circulation, so less sample volume yields richer biomarker data, making exosomes a potent source of early, actionable signals.
Originate from active cells
Abundant: 1,000x+ more plentiful than cf/ctDNA
DNA rich: Contain DNA, RNA, proteins, & metabolites
Ubiquitous: Secreted by all cell types & found in all biological fluids
Add Your Heading Text Here
Originate from active cells
Abundant: 1,000x+ more plentiful than cf/ctDNA
DNA rich: Contain DNA, RNA, proteins, & metabolites
Ubiquitous: Secreted by all cell types & found in all biological fluids
Add Your Heading Text Here
Groundbreaking Early Results
High performance early disease detection empowered by our breakthrough technology.
Novel Technology Built On A Strong Foundation
Years of R&D
Worldwide Patents
US Patents
Peer Reviewed Publications
Bringing Early Detection to Everyone, Everywhere
The team at Xzōm is committed to delivering accessible, affordable, and accurate near-patient solutions for the detection of disease in its earliest stages, enabling faster intervention and improved outcomes.
